Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic analysis of patients with nonsyndromic and syndromic retinitis pigmentosa in Puerto Rico: a genetic legacy. | Ophthalmic Genet | 2022 | 35318874 | PubTator, text mining | PubMed |
| The Current State of Genetic Testing Platforms for Inherited Retinal Diseases. | Ophthalmol Retina | 2022 | 35307606 | PubTator, text mining | PubMed |
| The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene. | Invest Ophthalmol Vis Sci | 2022 | 35293952 | PubTator, text mining | PubMed |
| Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer. | Mol Ther Oncolytics | 2022 | 35284626 | PubTator, text mining | PubMed |
| Analysis of cancer-promoting genes related to chemotherapy resistance in esophageal squamous cell carcinoma. | Ann Transl Med | 2022 | 35282117 | PubTator, text mining | PubMed |
| Exploring Immune-Related Prognostic Signatures in the Tumor Microenvironment of Colon Cancer. | Front Genet | 2022 | 35281839 | PubTator, text mining | PubMed |
| The Clinical Prediction Value of the Ubiquitination Model Reflecting the Immune Traits in LUAD. | Front Immunol | 2022 | 35281055 | PubTator, text mining | PubMed |
| Genomic landscape and prognosis of patients with TP53-mutated non-small cell lung cancer. | Ann Transl Med | 2022 | 35280362 | PubTator, text mining | PubMed |
| Establishing a Prognostic Model Based on Ulceration and Immune Related Genes in Melanoma Patients and Identification of EIF3B as a Therapeutic Target. | Front Immunol | 2022 | 35273605 | PubTator, text mining | PubMed |
| Deciphering the Potential Coding of Human Cytomegalovirus: New Predicted Transmembrane Proteome. | Int J Mol Sci | 2022 | 35269907 | PubTator, text mining | PubMed |
| Tissue-specific genotype-phenotype correlations among USH2A-related disorders in the RUSH2A study. | Hum Mutat | 2022 | 35266249 | PubTator, text mining | PubMed |
| Early disruption of photoreceptor cell architecture and loss of vision in a humanized pig model of usher syndromes. | EMBO Mol Med | 2022 | 35254721 | PubTator, text mining | PubMed |
| Generation of a human iPSC line, INMi005-A, from a patient with non-syndromic USH2A-associated retinitis pigmentosa. | Stem Cell Res | 2022 | 35248879 | PubTator, text mining | PubMed |
| The Predictive Value of PAK7 Mutation for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Cancer. | Front Immunol | 2022 | 35242138 | PubTator, text mining | PubMed |
| Methylation- and homologous recombination deficiency-related mutant genes predict the prognosis of lung adenocarcinoma. | J Clin Lab Anal | 2022 | 35238419 | PubTator, text mining | PubMed |
| Signal peptide peptidase: a potential therapeutic target for parasitic and viral infections. | Expert Opin Ther Targets | 2022 | 35235480 | PubTator, text mining | PubMed |
| Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants. | Hum Genet | 2022 | 35226187 | PubTator, text mining | PubMed |
| microRNA, a Subtle Indicator of Human Cytomegalovirus against Host Immune Cells. | Vaccines (Basel) | 2022 | 35214602 | PubTator, text mining | PubMed |
| Oligonucleotide Therapeutics: From Discovery and Development to Patentability. | Pharmaceutics | 2022 | 35213992 | PubTator, text mining | PubMed |
| Maternal Uniparental Isodisomy of Chromosome 4 and 8 in Patients with Retinal Dystrophy: SRD5A3-Congenital Disorders of Glycosylation and RP1-Related Retinitis Pigmentosa. | Genes (Basel) | 2022 | 35205402 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=38